These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 11004129)

  • 1. Presentation of amyloidosis in carriers of the codon 692 mutation in the amyloid precursor protein gene (APP692).
    Roks G; Van Harskamp F; De Koning I; Cruts M; De Jonghe C; Kumar-Singh S; Tibben A; Tanghe H; Niermeijer MF; Hofman A; Van Swieten JC; Van Broeckhoven C; Van Duijn CM
    Brain; 2000 Oct; 123 ( Pt 10)():2130-40. PubMed ID: 11004129
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Presenile Alzheimer dementia characterized by amyloid angiopathy and large amyloid core type senile plaques in the APP 692Ala-->Gly mutation.
    Cras P; van Harskamp F; Hendriks L; Ceuterick C; van Duijn CM; Stefanko SZ; Hofman A; Kros JM; Van Broeckhoven C; Martin JJ
    Acta Neuropathol; 1998 Sep; 96(3):253-60. PubMed ID: 9754958
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Presenile dementia and cerebral haemorrhage linked to a mutation at codon 692 of the beta-amyloid precursor protein gene.
    Hendriks L; van Duijn CM; Cras P; Cruts M; Van Hul W; van Harskamp F; Warren A; McInnis MG; Antonarakis SE; Martin JJ
    Nat Genet; 1992 Jun; 1(3):218-21. PubMed ID: 1303239
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinical and neuropathological features of the arctic APP gene mutation causing early-onset Alzheimer disease.
    Basun H; Bogdanovic N; Ingelsson M; Almkvist O; Näslund J; Axelman K; Bird TD; Nochlin D; Schellenberg GD; Wahlund LO; Lannfelt L
    Arch Neurol; 2008 Apr; 65(4):499-505. PubMed ID: 18413473
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Genetic determinants of white matter hyperintensities and amyloid angiopathy in familial Alzheimer's disease.
    Ryan NS; Biessels GJ; Kim L; Nicholas JM; Barber PA; Walsh P; Gami P; Morris HR; Bastos-Leite AJ; Schott JM; Beck J; Mead S; Chavez-Gutierrez L; de Strooper B; Rossor MN; Revesz T; Lashley T; Fox NC
    Neurobiol Aging; 2015 Dec; 36(12):3140-3151. PubMed ID: 26410308
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Molecular and prospective phenotypic characterization of a pedigree with familial Alzheimer's disease and a missense mutation in codon 717 of the beta-amyloid precursor protein gene.
    Karlinsky H; Vaula G; Haines JL; Ridgley J; Bergeron C; Mortilla M; Tupler RG; Percy ME; Robitaille Y; Noldy NE
    Neurology; 1992 Aug; 42(8):1445-53. PubMed ID: 1520398
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinical findings in nondemented mutation carriers predisposed to Alzheimer's disease: a model of mild cognitive impairment.
    Almkvist O; Axelman K; Basun H; Jensen M; Viitanen M; Wahlund LO; Lannfelt L
    Acta Neurol Scand Suppl; 2003; 179():77-82. PubMed ID: 12603253
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hemorrhage is uncommon in new Alzheimer family with Flemish amyloid precursor protein mutation.
    Brooks WS; Kwok JB; Halliday GM; Godbolt AK; Rossor MN; Creasey H; Jones AO; Schofield PR
    Neurology; 2004 Nov; 63(9):1613-7. PubMed ID: 15534244
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Genetic risk and transcriptional variability of amyloid precursor protein in Alzheimer's disease.
    Brouwers N; Sleegers K; Engelborghs S; Bogaerts V; Serneels S; Kamali K; Corsmit E; De Leenheir E; Martin JJ; De Deyn PP; Van Broeckhoven C; Theuns J
    Brain; 2006 Nov; 129(Pt 11):2984-91. PubMed ID: 16931535
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Diffusion tensor imaging in preclinical and presymptomatic carriers of familial Alzheimer's disease mutations.
    Ringman JM; O'Neill J; Geschwind D; Medina L; Apostolova LG; Rodriguez Y; Schaffer B; Varpetian A; Tseng B; Ortiz F; Fitten J; Cummings JL; Bartzokis G
    Brain; 2007 Jul; 130(Pt 7):1767-76. PubMed ID: 17522104
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A follow-up study of the family with the Swedish APP 670/671 Alzheimer's disease mutation.
    Wahlund LO; Basun H; Almkvist O; Julin P; Axelman K; Shigeta M; Jelic V; Nordberg A; Lannfelt L
    Dement Geriatr Cogn Disord; 1999; 10(6):526-33. PubMed ID: 10559570
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Flemish and Dutch mutations in amyloid beta precursor protein have different effects on amyloid beta secretion.
    De Jonghe C; Zehr C; Yager D; Prada CM; Younkin S; Hendriks L; Van Broeckhoven C; Eckman CB
    Neurobiol Dis; 1998 Oct; 5(4):281-6. PubMed ID: 9848098
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A large Swedish family with Alzheimer's disease with a codon 670/671 amyloid precursor protein mutation. A clinical and genealogical investigation.
    Axelman K; Basun H; Winblad B; Lannfelt L
    Arch Neurol; 1994 Dec; 51(12):1193-7. PubMed ID: 7986173
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cerebral amyloid angiopathy and dementia.
    Tian J; Shi J; Mann DM
    Panminerva Med; 2004 Dec; 46(4):253-64. PubMed ID: 15876981
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Dense-core senile plaques in the Flemish variant of Alzheimer's disease are vasocentric.
    Kumar-Singh S; Cras P; Wang R; Kros JM; van Swieten J; Lübke U; Ceuterick C; Serneels S; Vennekens K; Timmermans JP; Van Marck E; Martin JJ; van Duijn CM; Van Broeckhoven C
    Am J Pathol; 2002 Aug; 161(2):507-20. PubMed ID: 12163376
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cerebral amyloid angiopathy is a pathogenic lesion in Alzheimer's disease due to a novel presenilin 1 mutation.
    Dermaut B; Kumar-Singh S; De Jonghe C; Cruts M; Löfgren A; Lübke U; Cras P; Dom R; De Deyn PP; Martin JJ; Van Broeckhoven C
    Brain; 2001 Dec; 124(Pt 12):2383-92. PubMed ID: 11701593
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Autosomal-dominant Alzheimer's disease mutations at the same codon of amyloid precursor protein differentially alter Aβ production.
    Suárez-Calvet M; Belbin O; Pera M; Badiola N; Magrané J; Guardia-Laguarta C; Muñoz L; Colom-Cadena M; Clarimón J; Lleó A
    J Neurochem; 2014 Jan; 128(2):330-9. PubMed ID: 24117942
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinical comparison of Alzheimer's disease in pedigrees with the codon 717 Val-->Ile mutation in the amyloid precursor protein gene.
    Mullan M; Tsuji S; Miki T; Katsuya T; Naruse S; Kaneko K; Shimizu T; Kojima T; Nakano I; Ogihara T
    Neurobiol Aging; 1993; 14(5):407-19. PubMed ID: 8247223
    [TBL] [Abstract][Full Text] [Related]  

  • 19. APP duplication is sufficient to cause early onset Alzheimer's dementia with cerebral amyloid angiopathy.
    Sleegers K; Brouwers N; Gijselinck I; Theuns J; Goossens D; Wauters J; Del-Favero J; Cruts M; van Duijn CM; Van Broeckhoven C
    Brain; 2006 Nov; 129(Pt 11):2977-83. PubMed ID: 16921174
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Multiple Approaches to Diffusion Magnetic Resonance Imaging in Hereditary Cerebral Amyloid Angiopathy Mutation Carriers.
    Schouten TM; de Vos F; van Rooden S; Bouts MJRJ; van Opstal AM; Feis RA; Terwindt GM; Wermer MJH; van Buchem MA; Greenberg SM; de Rooij M; Rombouts SARB; van der Grond J
    J Am Heart Assoc; 2019 Feb; 8(3):e011288. PubMed ID: 30717612
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.